Intellectual Property
Minneapolis/St. Paul
Rebutting a Merely Descriptive Refusal
Backward Citations
Inter Partes Review
Most Common Client Question
Calculating New Investments
Licensing Density
Challenges When Dealing with Patent Matters
Using Product Association with IP Assets
How Should IP be Considered for Growth?
Common Reasons Trademarks Are Rejected
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Patents 101
Litigation and BioSimilar Patenting
Scope Concepts and Headnotes
Patent Owner Rights
Value Management and Cash Flow
ITU
Importance of Post-Grant Proceedings
Specimen
How can OSS Negatively Affect a Company?
"Claims" of a Patent
Merely Descriptive Refusal
Approvals of BioSimilars in Europe
Claim Abstraction Theory
Claim Maps and BioSimilars
Merrifield Synthesis
Effective Stay Strategy
Patent Examination Process
Trademark
Standard for Getting a Patent
"How Much" - Audit Action Sheet
Evaluation Agreement and Computer Codes
Patent Portfolio and Budgets/Spending
Joint Venture Ground Rules
Segmenting a Portfolio
Get Your Assignments Straight - Contribution of Owners
Value Management Lifecycle
Inventorship vs Ownership
Freedom to Operate (FTO) Process
Cost of Registering a Trademark
"Whens" - Audit Action Sheet
Two Main Value Drivers
Open Source Initiative
Is A United States Registered Trademark Effective in Other Countries?
Discovering Annuity Information
Technical Background
Moderate Risk Joint Ventures
Seeking Money from Investors
Types of Intellectual Property Protection
Attributes of a Good Patent
What Doesn't a Patent Provide?
Cost/Value Curve of a High Level Patent
The Advantage of Filing First
Repeating Competitor Audits
What Do I Give up in Getting My Patent?
By the Numbers Overview
Naming Problems with BioSimilars
How to Remedy Unwanted Disclosure of Confidential Information
Joint Venture and Financial Agreements
Consequences of a Poorly Drafted Patent
Importance of Freedom To Operate
Third Party Confidentiality
Post-Grant Options and Cost
PTAB Timing Trial Dynamics
Am I Required to Search for Prior Art?
Tools for Auditing a Patent Portfolio
Infringement on the Rights of Other Patents
Interpretational Differences Between Prosecution and Litigation
The Five Components of an Open Source Software Policy
Risk Profile
Qualifying for a Patent
Hard Assets
Meet Mark Stignani
Unanticipated OSS
Attorneys Not Understanding the Market
Mitigating Risks of Past Damages
Covered Business Method Review
Inventors and Patent Analytics
Confidential Information
"Wheres" - Audit Action Sheet
How is Open Source Software Enforced?
Patent Status Updates
Date of First Use
Secondary Meaning of a Trademark
Factors That Make a Patent Valuable
Meet David Black
Should IP be Part of Our Business Plan?
How is Schwegman Lundberg & Woessner Different?
Different Parts of a Patent Document
Hiring Patent Council
Post-Grant Options
Value-Driven Patent Portfolio
Copyright
Provisional Patent
Rewards of the Practice
A Less Expensive Alternative
What Should a Company Patent?
Why Do You Enjoy Being a Lawyer?
Researching Competitors' IP
Becoming a Patent Lawyer
Wasting Money on Low-Value Patents
Attorneys and Patent Profile Analytics
Trade Dress
5 Year View Point
How is the Entire Patent Considered Prior Art?
Importance of Getting a Patent
Why Perform Risk Profile?
What is a BioSimilar Product Under US Law?
Open Source Software
Establishing Confidentiality
Patents and Other Forms of Intellectual Property Protection
Post-Grant Options and Grounds of Challenge
NDAs and Computer Codes
What is a Trademark?
What is a BioSimilar?
Requirements to Receive a Patent
FDA Guidelines for Demonstrating Biosimilarity
What is a Patent Portfolio?
Benefits of Audit Action Sheet
Patent Ownership and Patent Profile Analytics
High Risk Joint Ventures
Types of Inventions That Are Patentable
Common Law Trademark Rights
Who Determines Substitution Factors?
What is a Patent?
Audit Action Sheet
Provisional vs Non-Provisional Patent
How Much Does it Cost to Get a Patent?
Patent Infringement
Is There Still a Place for Traditional Re-Examination?
Patents and Practicing an Invention
NDAs and Customers
Reasons to Consider Joint Ventures
Are BioSimilars Being Approved in the US?
Post-Grant Proceedings
Trade Secrets
Background
Contractual Intellectual Property Rights
Managing OSS
Ideal Patent Strategy
How to Fix the Knowledge Gap
Intellectual Property Protection
"SM" Symbol
How Does the Knowledge Gap Develop?
Determining Likelihood of Confusion
Value Management and Risk Management
The Different Types of Marks
Litigation Density
What Makes Schwegman, Lundberg & Woessner Different?
When to Do a Freedom to Operate
Considerations Before Hiring IP Council
Risks of OSS
Low Risk Joint Ventures
Prior Art in Prosecution vs Prior Art in Litigation
Trademarks and Brand Value
Cost/Value Curve of Patent a Portfolio
Patent Citation Ranking
Experience
Picking a Domain Name
"Whats" - Audit Action Sheet
How Long Does an FTO Take?
Independent Claim vs Dependent Claim
Genericide
Portfolio Dashboard - Inventor Information
Impact of PTAB
What is Prior Art?
Infringing on Another Patent
Implementing a Value-Driven Portfolio Process
Joint Ventures and Dispute Resolution
Freedom To Operate
Why Is Executing an NDA Not Enough?
Auction Audit Sheet - Key Issues to Address
How Big Should My First Patent Be?
Patent Profile Analytics and Researchers
Important Attributes to Being a Successful Patent Lawyer
What Engineers Can Learn from Patent Profile Analytics
Intent of Patent Laws
Post-Grant Options and Estoppel
Prior Art and Rejections
What Does an Audit Action Sheet Look Like?
Downside of Static Budget Allocation for Patents
Helping In-House Council
How to Navigate BioSimilar Challenges
Biologics vs Small Molecules
Preventing "Genericide"
Post-Litigation Challenges
Impact of Post-Grant Proceedings
Marking a Product
First Item on IP To-Do List
How is Open Source Incorporated into Software?
Golden Rule of Auditing a Patent Portfolio
What IP Should I Spend Money on First?
Non-Disclosure Agreement
The Case of the Joint Marketing Agreement Gone Bad
Purposes of a Trademark
Renewing a Trademark Registration
Do Narrow Patents Add Value to a Portfolio?
Impact of US Hatch Waxman Act 1984
First Step in Performing a Patent Portfolio Audit
Demonstrating BioSimilarity Under U.S. Law
Trade Names vs Trademarks
Patent Profile Analytics and Engineers
Forward Citation Landscape
IP Registration Density
How Should IP be Considered for Acquisition?
Tracking Work History
Proper Way to Use a Trademark
When is a House like a Patent?
Improperly Marked Product
Picking a Trademark
Prior Art Challenge
A Better Way to Allocate Patent Application Budgets
Confidential Information and Business Damage
Limited Valuable Patents in Technology Area
Raising Good Prosecution Visibility
Soft Assets
Traditional Re-Examination
Office Action
BioSimilar Patenting Litigation Involving Large Amounts of Money
What is an Invention?
Consequences of Disclosing Confidential Information
Inventorship
Convergence Density
Budgeting for Drafting and Prosecution
What to Do When First Selecting a Mark
Trade Name Protection and Trademark Protection
Freedom To Operate vs Clearance
Circle "R"
"TM" Symbol
Categories of Marks
Assessing Executive Experience
Post-Grant Review
Limiting Issues Defined in District Court
Pre-Litigation Challenges
Process for Registering a Trademark in the United States
Post-Grant Proceedings and Patent Enforcement
PTAB Final Argument Trial Dynamics
Patent Trial and Appeal Board
Trademark Filing Considerations
Why Should Claims Not Be Read on the Prior Art?
How Do Patent Portfolio Values Become Concentrated over Time?
Why Are Biologicals so Important?
What Should a Company Understand at the End of an IP Audit?
Sponsor
Practicing an Invention
Goal of a Value-Driven Patent Portfolio
Domain Registration Considerations
Geographic Insight and Patent Profile Analytics
Patent Profile Analytics and Managers
Advantages of Registering a Trademark
Factors That Cause a Patent to Decline in Value
Joint Venture Pitfalls
"Who" - Audit Action Sheet
Freedom to Operate
Signing an NDA
Equal Value Patents
Broad Patent Claim
Risks of Not Patenting
Forms of Confidential Information
Schwegman Lundberg & Woessner & Post Grant Trial Practice
Steps to Obtaining a Patent
Outside of Law
Improving Patent Portfolio Value
Unlicensed Source Codes
Cited Art Landscape
Engineers Not Understanding Patents
Patent Strategy Considerations
How Does the Knowledge Gap Worsen Over Time?
Patent Analytics and Competition
How do Patent Prosecution Services Vary in Value?
Refused Trademark Recourse
4 Ways to Prepare your Patent Portfolio for Battle.
Biologics Price Competition and Innovation Act
OSS Licensing Conditions
Portfolio Mapping
